Syncom

Groningen, Netherlands Founded: 1988 • Age: 38 yrs Acquired By Gilde Healthcare
CRO that specializes in organic chemistry and offers custom synthesis solutions for drug discovery

About Syncom

Syncom is a company based in Groningen (Netherlands) founded in 1988 was acquired by Gilde Healthcare in April 2017.. Syncom operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and IRBM, among others.

  • Headquarter Groningen, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Gilde Healthcare

    (Apr 01, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Syncom

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (03 Sep 2015)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2016 Amount Grant - Syncom Valuation

investors

Sep, 2015 Amount Grant - Syncom Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Syncom

Syncom has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gilde Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity and venture captial firm focused on healthcare sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Syncom

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Syncom

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Syncom Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Syncom

Syncom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and IRBM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
domain founded_year HQ Location
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
domain founded_year HQ Location
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
domain founded_year HQ Location
Fluorinated compounds are synthesized and manufactured customly for various industries.
domain founded_year HQ Location
Integrated drug discovery and preclinical development services are provided.
domain founded_year HQ Location
Small organic molecules are supplied for biotech and pharmaceutical R&D.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Syncom

Frequently Asked Questions about Syncom

When was Syncom founded?

Syncom was founded in 1988 and raised its 1st funding round 27 years after it was founded.

Where is Syncom located?

Syncom is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.

What does Syncom do?

A majority of Syncoms custom synthesis projects are focused on synthesising novel building blocks, intermediates and APIs for the pharmaceutical industry. In addition to regular custom synthesis projects, they also specialise in chiral technology and offer medicinal chemistry services including in vitro screening, ADME studies, pharmacokinetics and in vivo pharmacology through their partnerships with other European CROs. The company offers lead optimisation services through its preferred partners Brains-on-Line and Integrex Research.

Who are the top competitors of Syncom?

Syncom's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.

Who are Syncom's investors?

Syncom has 1 investor. Key investors include Gilde Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available